-
Viral RIPK3 Degradation and Inflammation
2026-08-11
Liu et al. identified vIRD, an orthopoxvirus protein that recruits SCF machinery to ubiquitinate and degrade the necroptosis adaptor RIPK3. Genetic gain- and loss-of-function experiments showed that vIRD-dependent control of RIPK3 can increase viral replication, inflammation, and disease severity, revealing a direct pathogen–host evolutionary interface.
-
O-propargyl-puromycin for Translational Flux
2026-08-11
O-propargyl-puromycin (OPP) converts short-term translation activity into a measurable molecular signal. This article explains how to use OPP to interrogate the Pcbp1–Fdxr–mitochondrial axis in B cells while avoiding common errors in protein synthesis interpretation.
-
Geneticin, G-418 Sulfate: Practical Guide
2026-08-10
Geneticin, G-418 Sulfate is an aminoglycoside selection antibiotic for isolating and maintaining cells carrying the neomycin resistance gene, with an additional dossier-supported DENV-2 research application. Its concentration must be optimized by cell-line-specific kill curves, and the reported antiviral activity should not be generalized beyond the stated BHK and DENV-2 context.
-
Lisinopril Dihydrate: From ACE to Translation
2026-08-09
A mechanistic and translational framework for using lisinopril dihydrate as an ACE inhibitor reference standard across hypertension, heart failure, acute myocardial infarction, and diabetic nephropathy research.
-
p-Cresyl Sulfate in Aortic Valve Calcification
2026-08-08
The reference study identifies p-cresyl sulfate as a mechanistic enhancer of calcification in aortic valvular interstitial cells and connects this effect to HIF-1α activation, klotho suppression, and NF-κB/RUNX2 signaling. Its porcine cell and rat chronic kidney disease models also suggest that klotho or SIRT1 activation may attenuate uremic toxin-associated valve remodeling, while highlighting the need for further translational validation.
-
Protein A/G Magnetic Beads for Vascular IP
2026-08-07
Protein A/G Magnetic Beads use recombinant Protein A and Protein G domains to capture IgG antibodies through Fc-region binding. The K1305 format supports antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows while providing a practical route to study TPM3–HDAC3 biology.
-
TCF25 Mediates Lysosomal Adaptation and Cell Death Under Glu
2026-08-07
Ren et al. (2025) reveal TCF25 as a pivotal nutrient sensor that enhances lysosomal acidification and orchestrates metabolic adaptation during glucose starvation, ultimately triggering lysosome-dependent cell death via ferritinophagy. This mechanistic insight highlights new therapeutic avenues for metabolic and ischemic disorders where nutrient stress and iron metabolism intersect.
-
SIRT1/2 Inhibitor IV (cambinol): Precision for CNS and Tumor
2026-08-06
SIRT1/2 Inhibitor IV (cambinol) enables researchers to dissect SIRT-regulated epigenetic and metabolic pathways in both CNS injury and cancer models. This guide delivers actionable workflows, troubleshooting strategies, and highlights a breakthrough mechanism—SIRT1-regulated Ran lactylation—linking metabolism to astrocyte function.
-
Standardized Whole-Blood Stimulation Reveals Metabolic Contr
2026-08-06
This study introduces a rigorously standardized protocol for assessing immune responses in human whole blood under defined metabolic modulation. The approach demonstrates how selective metabolic inhibitors, including those targeting mitochondrial pathways, can dissect cytokine production dynamics, providing a robust foundation for translational immunometabolism research.
-
Peripheral RIPK1 and IL-8 as ALS Biomarkers: Primidone’s Rol
2026-08-05
Wei et al. demonstrate that peripheral levels of RIPK1 and IL-8 are significantly elevated in amyotrophic lateral sclerosis (ALS) patients, and that pharmacological inhibition of RIPK1 by Primidone lowers these biomarkers. This work establishes RIPK1 and IL-8 as quantifiable peripheral biomarkers for ALS, supporting the repurposing of Primidone (Mysoline) as a potential therapeutic strategy.
-
p-Cresyl Sulfate in Endothelial Dysfunction & Calcification
2026-08-05
p-Cresyl sulfate enables high-fidelity modeling of uremic toxin-induced vascular calcification, bridging CKD-related endothelial dysfunction and cardiovascular risk. This article details advanced experimental workflows, troubleshooting guidance, and protocol enhancements using APExBIO's high-purity p-tolyl hydrogen sulfate.
-
Kanamycin Sulfate: Water-Soluble Antibiotic for Precision Re
2026-08-04
Kanamycin Sulfate is a water-soluble antibiotic with validated bactericidal efficacy due to inhibition of bacterial protein synthesis. Its high purity (>98%) and specific solubility profile make it a standard for antibiotic resistance research and RNA workflow integration.
-
Re-evaluation of Aminopeptidase and ACE Inhibitor Specificit
2026-08-04
This study systematically compared the inhibitory profiles of multiple metallopeptidase inhibitors, including ACE inhibitors, on three key mammalian zinc aminopeptidases: AP-N, AP-A, and AP-W. The findings clarify the selectivity and off-target actions of widely used compounds, with direct implications for hypertension, cardiovascular, and peptide metabolism research.
-
Apicidin Impairs Oocyte Quality by Disrupting Meiotic and Ep
2026-08-03
A recent study demonstrates that Apicidin, a selective histone deacetylase inhibitor and emerging mycotoxin, impairs oocyte maturation by disrupting the meiotic apparatus and altering histone acetylation. These findings highlight a novel mechanism of reproductive toxicity and stress the importance of evaluating HDAC inhibitor exposure in germ cell research.
-
p-Cresyl Sulfate in Vascular Calcification and Endothelial M
2026-08-03
p-Cresyl sulfate is transforming the study of uremic toxin-driven cardiovascular pathology, offering researchers a robust tool for simulating endothelial dysfunction and vascular calcification in chronic kidney disease. Here, we translate recent mechanistic breakthroughs into optimized protocols, troubleshooting tactics, and experimental innovations for high-impact vascular complication studies.